Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends in new HIV diagnoses and factors contributing to late diagnosis among migrant populations in EU/EEA countries, 2014 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

Same author

Characteristic SNPs defining the major multidrug-resistant <i>Mycobacterium tuberculosis</i> clusters identified by EuSeqMyTB to support routine surveillance, EU/EEA, 2017 to 2019.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

Same author

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023

Same author

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023

Same author

Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.

BMC infectious diseases·2022

Same author

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.

Emerging infectious diseases·2021

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Evaluating tuberculosis case detection in Eritrea.

Marieke J van der Werf¹, Mineab Sebhatu, Martien W Borgdorff

¹KNCV Tuberculosis Foundation, The Hague, the Netherlands. vanderwerfm@kncvtbc.nl

Emerging Infectious Diseases

|February 9, 2008

Summary

Tuberculosis case detection in Eritrea is significantly underestimated. A national survey revealed a case detection rate (CDR) of 40%, far exceeding the World Health Organization

Area of Science:

Public Health
Epidemiology
Infectious Disease Research

Background:

Tuberculosis (TB) remains a significant global health challenge.
Accurate case detection rates (CDR) are crucial for effective TB control programs.
Previous estimates of TB CDR in Eritrea may not reflect the true prevalence.

Purpose of the Study:

To calculate the actual case detection rate (CDR) of tuberculosis in Eritrea using national survey data.
To compare the survey-derived CDR with previously published figures.

Main Methods:

Utilized data from a national tuberculosis prevalence survey conducted in Eritrea.
Calculated the case detection rate (CDR) based on survey findings.
Compared the calculated CDR with published CDR data.

Related Experiment Videos

Last Updated: Jul 7, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Main Results:

The national tuberculosis prevalence survey in Eritrea yielded a case detection rate (CDR) of approximately 40%.
This survey-derived CDR is substantially higher, nearly three times greater, than the 14% CDR previously reported by the World Health Organization (WHO).

Conclusions:

Published tuberculosis case detection rates for Eritrea significantly underestimate the actual disease burden.
The findings highlight a critical need to re-evaluate TB control strategies and reporting mechanisms in Eritrea.
Further investigation into the discrepancies between survey data and reported figures is warranted.